(Q41952721)

14 October 2017

title

Glutamatergic system abnormalities in posttraumatic stress disorder (English)

1 reference

14 October 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kenji Hashimoto

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Yutaka Matsuoka

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

4

Kei Hamazaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

5

Tomohito Hamazaki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

3

Hiroko Noguchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

22 August 2015

1 reference

14 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

4261-4268

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

Plasma and platelet excitatory amino acids in psychiatric disorders.

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Reliability and validity of the Japanese-language version of the impact of event scale-revised (IES-R-J): four studies of different traumatic events.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

The development of a Clinician-Administered PTSD Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Simultaneous determination of D- and L-serine in rat brain microdialysis sample using a column-switching HPLC with fluorimetric detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Emerging role of glutamate in the pathophysiology of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Targeting of NMDA receptors in new treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Increased levels of glutamate in brains from patients with mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Old drug ifenprodil, new hope for PTSD with a history of childhood abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Posttraumatic stress disorder in the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Screening for psychological distress in Japanese cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Increased cerebrospinal fluid glutamine levels in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

The Tachikawa cohort of motor vehicle accident study investigating psychological distress: design, methods and cohort profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Glutamate receptors in extinction and extinction-based therapies for psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Incidence and prediction of post-traumatic stress disorder at 6 months after motor vehicle accidents in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

New perspectives in glutamate and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Ifenprodil for the treatment of flashbacks in adolescent female posttraumatic stress disorder patients with a history of abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Effects of carbamazepine, phenytoin, lamotrigine, oxcarbazepine, topiramate and vinpocetine on Na+ channel-mediated release of [3H]glutamate in hippocampal nerve endings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Health care costs associated with posttraumatic stress disorder symptoms in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Reevaluating the association between emergency department heart rate and the development of posttraumatic stress disorder: A public health approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-015-4052-5

Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls.

21 January 2018

1 reference

12 December 2020

Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation

1 reference

12 December 2020

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

12 December 2020

Correlation between plasma levels of glutamate, alanine and serine with severity of depression

1 reference

12 December 2020

The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA)

1 reference

12 December 2020

The injury severity score: an update

1 reference

12 December 2020

Post-traumatic stress disorder in the community: an epidemiological study

1 reference

12 December 2020

Increased serum glutamate in depressed patients

1 reference

12 December 2020

Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment

1 reference

12 December 2020

10.1007/S00213-015-4052-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 June 2020

1047860046

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26292802%20AND%20SRC:MED&resulttype=core&format=json